Journal of Thoracic Oncology

Published by: Elsevier Inc.  

People

  1. Ladanyi
    Ladanyi
  2. Kris
    Kris
  3. Riely
    Riely
  4. Rekhtman
    Rekhtman
  5. Drilon
    Drilon
  6. Arcila
    Arcila
  7. Yu
    Yu
  8. Offin
    Offin
  9. Rusch
    Rusch
  10. Rudin
    Rudin

Groups

  1. GSK Faculty (71)
  2. Human Oncology and Pathogenesis Program (71)
  3. Tow Center for Developmental Oncology (TCDO) (71)
  4. Department of Medicine (63)
  5. Solid Tumor Oncology Division (63)
  6. Thoracic Oncology (62)
  7. Sloan Kettering Institute Postdocs (23)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (19)
  9. Surgery (19)
  10. Biostatistics Service (18)
Search Within
  1. "Marc Ladanyi"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (33)
Groups
  1. GSK Faculty (71)
  2. Human Oncology and Pathogenesis Program (71)
  3. Tow Center for Developmental Oncology (TCDO) (71)
  4. Department of Medicine (63)
  5. Solid Tumor Oncology Division (63)
  6. Thoracic Oncology (62)

More Groups

People
  1. Marc Ladanyi (71)
  2. Mark Kris (36)
  3. Gregory Riely (31)
  4. Natasha Rekhtman (21)
  5. Maria Arcila (20)
  6. Alexander Drilon (17)

More People

Years
  1. 2024 (2)
  2. 2023 (7)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (3)
  6. 2019 (11)

More Years

Publishers
  1. Elsevier Inc. (71)

Results (71)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • HER4 and EGFR activate cell signaling in NRG1 fusion-driven cancers: Implications for HER2-HER3-specific versus pan-HER targeting strategies
    Journal Article

    Udagawa, H.; Nilsson, M. B.; Robichaux, J. P.; He, J.; Poteete, A.; Jiang, H.; Heeke, S.; Elamin, Y. Y.; Shibata, Y.; Matsumoto, S.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Microsatellite instability defines a subset of lung cancers with smoking exposure, high tumor mutational burden and MLH1 inactivation
    Meeting Abstract

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benhamida, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in NSCLC
    Journal Article

    Alessi, J. V.; Wang, X.; Elkrief, A.; Ricciuti, B.; Li, Y. Y.; Gupta, H.; Spurr, L. F.; Rizvi, H.; Luo, J.; Pecci, F.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
    Journal Article

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Journal Article

    Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save

    • Journal of Thoracic Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Science, Inc.
    Journal of Thoracic Oncology 1556-1380 Elsevier Inc.
    Journal of Thoracic Oncology 15561380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Science, Inc.
    Journal of Thoracic Oncology 1556-1380 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Lippincott Williams & Wilkins
    Journal of Thoracic Oncology 1556-1380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 2019
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15561380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 0959-8049 Unknown
    Journal of Thoracic Oncology 15560864 2022
    Journal of Thoracic Oncology 15560864 2021
    Journal of Thoracic Oncology 15560864 2023
    Journal of Thoracic Oncology 1556-0864 Elsevier Science, Inc.
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15561380 Unknown
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 Unknown
    Journal of Thoracic Oncology 15560864 2012
    Journal of Thoracic Oncology 1556-1380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 International Association
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Unknown
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 15561380 Unknown
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 1556-1380 Ovid Technologies, Inc.